Delivery Order SPE2DB24D8002-SPE2DB24FJMPF
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$5.3K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,958.24, is a firm-fixed-price delivery order for 4,567,087,425 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of January 30, 2025 and was awarded on January 29, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment...
This delivery order contract, valued at $1,993.90, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of 4,563,982 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, with a performance period through March 18, 2024. This award is made as a firm fixed-price delivery order without any set-aside designation. Dakota Drug, Inc. has a long-standing history as a...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,928.10, is for the delivery of 4563372594 - Ondansetron ODT 4 mg tablets. The contract has a period of performance through January 22, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Ondansetron ODT 4 mg tablets. The $3,095.46 firm fixed-price contract has a performance period extending to February 7, 2025. This award is part of Dakota Drug's single-award Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00. This IDC allows Dakota...
This federal contract award, identified as SPE2DX15D8002 and SPE2DX23F3AC4, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $5,825.10, is for the delivery of 4562235187 Ondansetron ODT 4 mg tablets in 30-count packages. This is a firm fixed-price delivery order contract with an ultimate completion date of September 20, 2023. Dakota Drug, Inc. is an established federal...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKYXK, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,759.71, is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages. This award is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical products,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Ondansetron ODT 4 mg tablets, a prescription medication, to support U.S. Armed Forces medical operations. The contract has a ceiling value of $1,649.98 and a performance period that runs through November 22, 2024. This Delivery Order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2UB4, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $6,964.67, is for the delivery of Ondansetron ODT 4 mg tablets in 30-count packages. This is a firm-fixed-price delivery order contract with a completion date of December 8, 2023. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $6,936.33, is for the delivery of 4,568,174,620 units of Ondansetron ODT 4 mg tablets. The contract has an ultimate completion date of May 8, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,280.00 fixed-price contract is for the delivery of 4 mg Ondansetron orally disintegrating tablets in 30-count packages. The contract is not set aside and has a performance period through February 12, 2025. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the agency's ECAT Generation V...